Hooper from The University of Queensland is working at Brisbane's Translational
Research Institute to develop a new way to detect and treat Pancreatic Cancer.
With 70-80% of Pancreatic Cancer patients diagnosed in the late stages with
limited treatment options, Prof Hooper is aiming to develop new
precision-medicine agents called theranostics for the detection and treatment.
He was awarded a 2019 Avner Foundation Innovation Grant to continue his work. | https://www.youtube.com/watch?v=DsP2dVeA9nw&feature=youtu.be